MYC inhibition by Omomyc as a therapeutic strategy for (KRAS-mutated) colorectal cancer

被引：0
|
作者：
Kaur, J. [1 ]
Martinez-Martin, S. [2 ]
Foradada, L. [2 ]
Lopez-Estevez, S. [2 ]
Serrano, E. [1 ]
Martin-Fernandez, G. [1 ]
Thabussot, H. [3 ]
Cano, V. Castillo [3 ]
Casacuberta-Serra, S. [4 ]
Zacarias-Fluck, M. F. [1 ]
Grueso, J. [1 ]
Beaulieu, M. E. [5 ]
Whitfield, J. R.
Soucek, L. [1 ,5 ,6 ,7 ]
机构：
[1] Vall dHebron Inst Oncol, Models Canc Therapies Grp, Barcelona, Spain
[2] Peptomyc SL, Biomarkers, Barcelona, Spain
[3] Peptomyc SL, Prot Prod Platform, Barcelona, Spain
[4] Peptomyc SL, Immuno Oncol, Barcelona, Spain
[5] Peptomyc SL, Peptomyc, Barcelona, Spain
[6] Inst Catalana Recerca & Estudis Avancats, Icrea, Barcelona, Spain
[7] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Sotorasib in KRAS-Mutated Colorectal Cancer
    Fojo, Tito
    Fakih, Marwan G.
    Chao, Joseph
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 186 - 187
  • [2] The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
    Tria, Simon Manuel
    Burge, Matthew E.
    Whitehall, Vicki L. J.
    CANCERS, 2023, 15 (08)
  • [3] Microenvironment targets in KRAS-mutated metastatic colorectal cancer
    Marchio, Serena
    Bartolini, Alice
    Cardaci, Sabrina
    Soster, Marco
    Corti, Giorgio
    Lamba, Simona
    Bussolino, Federico
    Cora', Davide
    Nicolantonio, Federica D.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] MicroRNA signature associated with KRAS-mutated colorectal cancer
    Andreoiu, O-M
    Dobre, M.
    Pirvu, I-R
    Vasilescu, F.
    Herlea, V.
    Becheanu, G.
    VIRCHOWS ARCHIV, 2017, 471 : S161 - S162
  • [5] Novel therapeutic strategy for Kras mutated colorectal cancer and PDAC
    Obi, Natsuno
    Takeda, Mizuho
    Masuda, Tatsuya
    Yanagida, Yohei
    Kobayakawa, Atsushi
    Sakuramoto, Naoya
    Hada, Asuka
    Horiuchi, Ayaka
    Sasaki, Asami
    Takeda, Kanako
    Matsuo, Hidemasa
    Adachi, Souichi
    Kamikubo, Yasuhiko
    CANCER SCIENCE, 2021, 112 : 434 - 434
  • [6] Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
    Stebbing, Justin
    Bullock, Andrea J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2005 - 2007
  • [7] Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer
    Dimou, Anastasios
    Syrigos, Konstantinos
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2011, 22 (05) : 384 - 391
  • [8] Advanced therapies on BRAF-mutated and KRAS-mutated metastatic colorectal cancer
    LI Zi-nan
    YU Li-feng
    WANG Jia-qi
    NIU Yan-xin
    WANG Xin-yu
    ZHAO Lin
    中国药理学与毒理学杂志, 2019, (10) : 883 - 883
  • [9] Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
    Jiffry, Jeeshan
    Thavornwatanayong, Thongthai
    Rao, Devika
    Fogel, Elisha J.
    Saytoo, Durvanand
    Nahata, Rishika
    Guzik, Hillary
    Chaudhary, Imran
    Augustine, Titto
    Goel, Sanjay
    Maitra, Radhashree
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 865 - 876
  • [10] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Hirata, Yuki
    Otsuki, Yuji
    Suina, Kentaro
    Saito, Yoshiyuki
    Masuda, Kenta
    Okazaki, Shogo
    Ishimoto, Takatsugu
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2022, 113 (03) : 916 - 925
12345